Showing results (71-80 of 121) with videos related to
Sort By:
Pageof 13
Journal of the American Heart Association|March 21, 2015
Efficacy and safety of vorapaxar as approved for clinical use in the United StatesGiulia Magnani, Marc P Bonaca, Eugene Braunwald, et al.Plos One|May 17, 2019
Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shockToni Jäntti, Tuukka Tarvasmäki, Veli-Pekka Harjola, et al.Journal of the American College of Cardiology|May 7, 2011
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudyBenjamin M Scirica, Christopher P Cannon, Håkan Emanuelsson, et al.The American Journal of Cardiology|August 20, 2017
Frequency and Prognostic Significance of Abnormal Liver Function Tests in Patients With Cardiogenic ShockToni Jäntti, Tuukka Tarvasmäki, Veli-Pekka Harjola, et al.ESC Heart Failure|October 25, 2016
Ventricular conduction abnormalities as predictors of long-term survival in acute de novo and decompensated chronic heart failureHeli Tolppanen, Krista Siirila-Waris, Veli-Pekka Harjola, et al.Cardiorenal Medicine|January 21, 2020
Activation of the Nitric Oxide Pathway and Acute Myocardial Infarction Complicated by Acute Kidney InjuryJiri Parenica, Petr Kala, Alexandre Mebazaa, et al.Clinical Cardiology|June 10, 2017
Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trialCharles V Pollack, Farideh Davoudi, Deborah B Diercks, et al.European Journal of Internal Medicine|December 11, 2012
Long-term survival following acute heart failure: the Acute Heart Failure Database Main registry (AHEAD Main)Jiri Parenica, Jindrich Spinar, Jiri Vitovec, et al.European Journal of Heart Failure|March 31, 2015
Clinical picture and risk prediction of short-term mortality in cardiogenic shockVeli-Pekka Harjola, Johan Lassus, Alessandro Sionis, et al.European Heart Journal. Acute Cardiovascular Care|August 11, 2022
Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shockMari Hongisto, Johan Lassus, Tuukka Tarvasmäki, et al.Pageof 13